Panacea Biotec informs about resignation of director

10 Mar 2022 Evaluate
Panacea Biotec has informed that Shantanu Yeshwant Nalavadi, Non-Executive Nominee Director of the Company has, due to his professional commitments, tendered resignation from the Board of Directors of the Company vide his letter dated March 10, 2022. Shantanu Yeshwant Nalavadi was earlier nominated by Vistra ITCL (India)  acting as Debenture Trustee with respect to non-convertible debentures issued to India Resurgence Fund-Scheme 1, India Resurgence Fund-Scheme 2 and Piramal Enterprises which have been fully redeemed on March 03,2022. The said resignation has become effective from March 10, 2022. 

The above information is a part of company’s filings submitted to BSE.

Panacea Biotec Share Price

364.20 -4.40 (-1.19%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×